INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 86 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $617 | -100.0% | 16,554 | -86.2% | 0.00% | -85.7% |
| Q2 2022 | $6,190,000 | +618.1% | 119,600 | +191.7% | 0.01% | +600.0% |
| Q2 2020 | $862,000 | +60.2% | 41,000 | +11.7% | 0.00% | – |
| Q4 2019 | $538,000 | -80.0% | 36,700 | -77.7% | 0.00% | -100.0% |
| Q2 2019 | $2,695,000 | -13.4% | 164,600 | -27.8% | 0.00% | -33.3% |
| Q4 2018 | $3,112,000 | +913.7% | 228,000 | +1087.5% | 0.00% | – |
| Q2 2017 | $307,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |